These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24895896)

  • 41. Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase.
    Maccioni E; Alcaro S; Orallo F; Cardia MC; Distinto S; Costa G; Yanez M; Sanna ML; Vigo S; Meleddu R; Secci D
    Eur J Med Chem; 2010 Oct; 45(10):4490-8. PubMed ID: 20702005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selected furanochalcones as inhibitors of monoamine oxidase.
    Robinson SJ; Petzer JP; Petzer A; Bergh JJ; Lourens AC
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4985-9. PubMed ID: 23860591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoamine oxidase inhibition by selected anilide derivatives.
    Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
    Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.
    Sahoo A; Yabanoglu S; Sinha BN; Ucar G; Basu A; Jayaprakash V
    Bioorg Med Chem Lett; 2010 Jan; 20(1):132-6. PubMed ID: 19945874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase.
    Booysen HP; Moraal C; Terre'Blanche G; Petzer A; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Dec; 19(24):7507-18. PubMed ID: 22055712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
    Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
    Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
    J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steered molecular dynamics simulations reveal important mechanisms in reversible monoamine oxidase B inhibition.
    Allen WJ; Bevan DR
    Biochemistry; 2011 Jul; 50(29):6441-54. PubMed ID: 21682347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knowledge based identification of MAO-B selective inhibitors using pharmacophore and structure based virtual screening models.
    Boppana K; Dubey PK; Jagarlapudi SA; Vadivelan S; Rambabu G
    Eur J Med Chem; 2009 Sep; 44(9):3584-90. PubMed ID: 19321235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
    Pan ZX; He X; Chen YY; Tang WJ; Shi JB; Tang YL; Song BA; Li J; Liu XH
    Eur J Med Chem; 2014 Jun; 80():278-84. PubMed ID: 24793878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of monoamine oxidase by C5-substituted phthalimide analogues.
    Manley-King CI; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2011 Aug; 19(16):4829-40. PubMed ID: 21778064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
    Matos MJ; Vilar S; Gonzalez-Franco RM; Uriarte E; Santana L; Friedman C; Tatonetti NP; Viña D; Fontenla JA
    Eur J Med Chem; 2013 May; 63():151-61. PubMed ID: 23474901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B.
    Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6632-5. PubMed ID: 23010267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kinetic behavior and reversible inhibition of monoamine oxidases--enzymes that many want dead.
    Tipton KF; Davey GP; McDonald AG
    Int Rev Neurobiol; 2011; 100():43-64. PubMed ID: 21971002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
    Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
    Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs.
    Chaurasiya ND; Ganesan S; Nanayakkara NP; Dias LR; Walker LA; Tekwani BL
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1701-4. PubMed ID: 22264472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of selective inhibitors for computer modeling of the monoamine oxidase active site].
    Veselovskiĭ AV; Ivanov AS; Medvedev AE
    Vopr Med Khim; 1997; 43(6):527-36. PubMed ID: 9503570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors.
    Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Befani O; Turini P; Ortuso F; Alcaro S
    J Med Chem; 2007 Feb; 50(3):425-8. PubMed ID: 17266193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.
    Binda C; Wang J; Pisani L; Caccia C; Carotti A; Salvati P; Edmondson DE; Mattevi A
    J Med Chem; 2007 Nov; 50(23):5848-52. PubMed ID: 17915852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.